Pulse Biosciences (PLSE) Revenue (2021 - 2025)

Pulse Biosciences' (PLSE) quarterly Revenue came in at $86000.0 in Q3 2025, down 67.55% quarter-over-quarter from $265000.0 in Q2 2022.

Pulse Biosciences (PLSE) Revenue (2021 - 2025) Analysis & Trends

Pulse Biosciences' Revenue history runs 3 years deep, the most recent figure standing at $86000.0 for Q3 2025.

On a quarterly basis, Revenue changed N/A year-over-year to $86000.0 in Q3 2025; TTM through Sep 2025 was $86000.0, a N/A change from a year earlier, with the FY2022 full-year figure at $700000.0, down 50.0% from the prior year.
Revenue retreated to $86000.0 in Q3 2025 per PLSE's latest filing, from $265000.0 in the prior quarter.
Across five years, Revenue topped out at $826000.0 in Q4 2021 and bottomed at $86000.0 in Q3 2025.
The 3-year median for Revenue is $444000.0 (2022), against an average of $439000.0.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Revenue (Qtr)
1	Alcon	33,163,703.85 Bn	33,163,702.19 Bn	1.53 Bn	2.69 Bn
2	Intuitive Surgical	119.67 Bn	114.45 Bn	1.96 Bn	2.89 Bn
3	Becton Dickinson	43.92 Bn	43.11 Bn	2.15 Bn	4.71 Bn
4	Medline	31.71 Bn	29.47 Bn	1.84 Bn	7.35 Bn
5	Resmed	28.46 Bn	26.80 Bn	890.98 Mn	1.43 Bn
6	West Pharmaceutical Services	23.80 Bn	23.28 Bn	296.40 Mn	844.90 Mn
7	Cooper Companies	13.77 Bn	13.63 Bn	735.40 Mn	1.08 Bn
8	Solventum	13.63 Bn	13.06 Bn	1.10 Bn	2.01 Bn
9	Align Technology	11.94 Bn	10.88 Bn	736.59 Mn	1.04 Bn
10	Pulse Biosciences	2.03 Bn	1.95 Bn	-	-

Download Data